Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.68 USD | +0.31% |
|
+0.84% | +26.20% |
28/06 | Barclays Raises Catalent's Price Target to $63 From $47, Maintains Equalweight Rating | MT |
27/06 | Barclays Adjusts Catalent Price Target to $63 From $47 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.20% | 10.23B | |
+56.94% | 809B | |
+39.52% | 624B | |
-7.20% | 351B | |
+7.25% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.98% | 166B | |
-2.62% | 157B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Transcript : Catalent, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 10